scholarly journals Dietary protein affects the composition of weight loss in post‐menopausal women

2006 ◽  
Vol 20 (4) ◽  
Author(s):  
Stephen B Kritchevsky ◽  
Linda Easter ◽  
Mary Lyles ◽  
Denise K Houston ◽  
Kimberly Kennedy ◽  
...  
Keyword(s):  
Weight Loss ◽  
Dietary Protein ◽  
Menopausal Women ◽  
Post Menopausal

scholarly journals Adequate dietary protein is associated with better physical performance among post-menopausal women 60–90 years

2013 ◽  
Vol 18 (2) ◽  
pp. 155-160 ◽  
Author(s):  
L. Gregorio ◽  
J. Brindisi ◽  
A. Kleppinger ◽  
R. Sullivan ◽  
K. M. Mangano ◽  
...  
Keyword(s):  
Physical Performance ◽  
Dietary Protein ◽  
Menopausal Women ◽  
Post Menopausal

scholarly journals Long-term body composition improvement in post-menopausal women following bariatric surgery: a cross-sectional and case-control study

2021 ◽  
Author(s):  
Sara Santini ◽  
Nathalie Vionnet ◽  
Jérôme Pasquier ◽  
Michel Suter ◽  
Didier Hans ◽  
...  
Keyword(s):  
Bariatric Surgery ◽  
Weight Loss ◽  
Body Composition ◽  
Lipid Profile ◽  
Positive Impact ◽  
Case Control ◽  
Cross Sectional ◽  
Menopausal Women ◽  
Post Menopausal

Objective: Bariatric surgery (BS) induces loss of body fat mass (FM) with an inexorable loss of lean mass (LM). Menopause leads to deleterious changes in body composition (BC) related to estrogen deficiency including LM loss and increase in total and visceral adipose tissue (VAT). This study aims to describe long-term weight evolution of post-menopausal women after RYGB (Roux-en-Y gastric bypass) and to compare BC between BS patients versus post-menopausal non-operated women. Design: Cross-sectional study of 60 post-menopausal women who underwent RYGB ≥ two years prior to the study with nested case-control design. Methods: Post-menopausal BS women were matched for age and BMI with controls. Both groups had DXA scan, lipids and glucose metabolism markers assessment. Results: Median follow-up was 7.5(2–18) years. Percentage of total weight loss (TWL%) was 28.5±10%. After RYGB, LM percentage of body weight (LM%) was positively associated with TWL% and negatively associated with nadir weight. Forty-one post-BS women were matched with age- and BMI-controls. Post-BS patients showed higher LM% (57.7%[±8%] versus 52.5%[±5%], p=0.001), reduced FM% (39.4%[±8.4%] versus 45.9%[±5.4%] p<0.01) and lower VAT (750.6g[±496] versus 1295.3g[±688], p<0.01) with no difference in absolute LM compared to controls. While post-BS women showed a better lipid profile compared to controls, no difference was found in glucose markers. Conclusions: Post-menopausal women after RYGB have a lower FM and VAT, preserved LM and a better lipid profile compared to controls. Weight loss after RYGB seems to have a persistent positive impact on metabolic health.

scholarly journals Osteocalcin carboxylation is not associated with body weight or percent fat changes during weight loss in post-menopausal women

Endocrine ◽  
2015 ◽  
Vol 50 (3) ◽  
pp. 627-632 ◽  
Author(s):  
Amanda J. Centi ◽  
Sarah L. Booth ◽  
Caren M. Gundberg ◽  
Edward Saltzman ◽  
Barbara Nicklas ◽  
...  
Keyword(s):  
Weight Loss ◽  
Body Weight ◽  
Menopausal Women ◽  
Post Menopausal

scholarly journals Influence of dietary weight‐loss on vitamins D and K in obese post‐menopausal women

2010 ◽  
Vol 24 (S1) ◽  
Author(s):  
M. Kyla Shea ◽  
Barbara J. Nicklas ◽  
Denise K. Houston ◽  
Edward Saltzman ◽  
Stephen B. Kritchevsky ◽  
...  
Keyword(s):  
Weight Loss ◽  
Menopausal Women ◽  
Dietary Weight Loss ◽  
Post Menopausal

Effect of bariatric surgery on breast tissue and biomarkers in obese women at increased risk for breast cancer.

2017 ◽  
Vol 35 (15_suppl) ◽  
pp. TPS1592-TPS1592
Author(s):  
Tarah Jean Ballinger ◽  
Kathy Miller ◽  
Kandice Ludwig ◽  
Sunil S. Badve ◽  
Don Selzer ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Insulin Resistance ◽  
Bariatric Surgery ◽  
Weight Loss ◽  
Breast Cancer Risk ◽  
Breast Tissue ◽  
Obese Women ◽  
Increased Risk ◽  
Menopausal Women ◽  
Post Menopausal

TPS1592 Background: Obesity represents a challenging epidemic associated with increased risk of several malignancies, including breast cancer in post-menopausal women. Proposed mechanisms for the association between obesity and breast cancer risk include increased insulin resistance, elevated levels of circulating estrogens, and chronic inflammation. Intentional weight loss from bariatric surgery has been associated with decreased risk of breast cancer. While rapid improvements in serologic markers of metabolism and inflammation are seen following bariatric surgery, short- and long- term changes in breast tissue remain less clear. This study investigates the effect of bariatric surgery on breast density and biomarkers of increased risk in breast tissue. Methods: This pilot, single institution, observational study (NCT02681120) is recruiting pre- and post-menopausal women with BMI ≥30 from a University bariatric surgery clinic using the Hughes risk application as a screening tool. Eligible patients must have a lifetime risk for breast cancer of ≥20%. Participants are evaluated by imaging, breast biopsy, and blood samples at baseline, 14 days post-operatively to determine the effects of rapid metabolic changes, and 1 year post-operatively to determine the effects of significant weight loss. The impact of bariatric surgery on known imaging parameters of breast cancer risk is assessed by background parenchymal enhancement on MRI and breast density on mammogram. Breast tissue is evaluated for changes in immune infiltrates, aromatase expression, and the presence of crown-like structures, a marker of inflammation seen in the breast tissue of obese women. Tissue samples at each time point are also compared to samples from lean women in the Susan G. Komen Tissue Bank at the IU Simon Cancer Center. Blood is collected for correlative studies evaluating markers of inflammation, insulin resistance, metabolism, and hormone synthesis. Enrollment is currently ongoing with a planned accrual of 40 patients, and data collection is estimated to complete by the end of 2018. Clinical trial information: NCT02681120.

Sign in / Sign up

Export Citation Format

Share Document